The Role of Natural Killer, Complement and T-lymphocytes in COVID-19 Disease, a Prospective Monocentric Study
Clinical trial NCT05258643 · UNKNOWN
Trial details
- NCT number
- NCT05258643
- Sponsor
- Universitair Ziekenhuis Brussel
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-01
- Primary completion
- 2024-05-01
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.